Alcentra Capital Corp (NASDAQ:ABDC) Director Steven H. Reiff bought 11,668 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were purchased at an average price of $10.72 per share, for a total transaction of $125,080.96. Following the purchase, the director now owns 7,000 shares in the company, valued at approximately $75,040. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Alcentra Capital Corp (NASDAQ:ABDC) traded up 0.85% during mid-day trading on Friday, hitting $10.71. The company had a trading volume of 52,164 shares. The company has a 50-day moving average price of $12.15 and a 200 day moving average price of $13.08. Alcentra Capital Corp has a 52-week low of $10.20 and a 52-week high of $14.73.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 5th. Stockholders of record on Saturday, September 30th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 12.70%. The ex-dividend date of this dividend is Thursday, September 28th. Alcentra Capital Corp’s dividend payout ratio is presently -1,700.00%.
ILLEGAL ACTIVITY NOTICE: “Alcentra Capital Corp (NASDAQ:ABDC) Director Steven H. Reiff Acquires 11,668 Shares” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://stocknewstimes.com/2017/08/18/insider-buying-alcentra-capital-corp-nasdaqabdc-director-purchases-11668-shares-of-stock-updated.html.
Several equities research analysts have recently issued reports on ABDC shares. Keefe, Bruyette & Woods set a $13.00 target price on shares of Alcentra Capital Corp and gave the company a “hold” rating in a report on Sunday, August 6th. DA Davidson assumed coverage on shares of Alcentra Capital Corp in a report on Wednesday, July 5th. They issued a “buy” rating and a $15.00 target price for the company. TheStreet lowered shares of Alcentra Capital Corp from a “b” rating to a “c+” rating in a report on Monday, July 24th. Finally, Raymond James Financial, Inc. lowered shares of Alcentra Capital Corp from a “strong-buy” rating to an “outperform” rating and cut their target price for the company from $16.00 to $14.00 in a report on Monday, July 17th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Alcentra Capital Corp has a consensus rating of “Hold” and an average price target of $13.50.
Large investors have recently added to or reduced their stakes in the company. Royal Bank of Canada raised its stake in Alcentra Capital Corp by 1,948.4% in the second quarter. Royal Bank of Canada now owns 8,808 shares of the asset manager’s stock valued at $120,000 after buying an additional 8,378 shares in the last quarter. Bank of Montreal Can bought a new stake in Alcentra Capital Corp during the second quarter valued at $163,000. Wealthsource Partners LLC bought a new stake in Alcentra Capital Corp during the second quarter valued at $176,000. Oppenheimer & Co. Inc. raised its stake in Alcentra Capital Corp by 4.4% in the second quarter. Oppenheimer & Co. Inc. now owns 13,098 shares of the asset manager’s stock valued at $178,000 after buying an additional 550 shares in the last quarter. Finally, Stifel Financial Corp bought a new stake in Alcentra Capital Corp during the second quarter valued at $188,000. 28.44% of the stock is owned by institutional investors and hedge funds.
Alcentra Capital Corp Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Ratings for Alcentra Capital Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp and related companies with MarketBeat.com's FREE daily email newsletter.
